14
Views
10
CrossRef citations to date
0
Altmetric
Original

Influence of Glucose Control and Improvement of Insulin Resistance on Microvascular Blood Flow and Endothelial Function in Patients with Diabetes Mellitus Type 2

, , , , , , , & show all
Pages 543-550 | Received 04 Jan 2005, Accepted 14 Apr 2005, Published online: 10 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (10)

Jun Xu, Lijun Cao, Yuan Suo, Xiaoqin Xu, Hui Sun, Songao Xu, Xiangyun Zhu, Huijie Yu & Weizhong Cao. (2018) Chitosan-microcapsulated insulin alleviates mesenteric microcirculation dysfunction via modulating COX-2 and VCAM-1 expression in rats with diabetes mellitus. International Journal of Nanomedicine 13, pages 6829-6837.
Read now
Marija M. Polovina & Tatjana S. Potpara. (2014) Endothelial Dysfunction in Metabolic and Vascular Disorders. Postgraduate Medicine 126:2, pages 38-53.
Read now
Thomas Forst, Markolf Hanefeld & Andreas Pfützner. (2011) Review of approved pioglitazone combinations for type 2 diabetes. Expert Opinion on Pharmacotherapy 12:10, pages 1571-1584.
Read now
Hadi AR Hadi & Jassim Al Suwaidi. (2007) Endothelial dysfunction in diabetes mellitus. Vascular Health and Risk Management 3:6, pages 853-876.
Read now
Mozhgan Dorkhan & Anders Frid. (2007) A review of pioglitazone HCL and glimepiride in the treatment of type 2 diabetes. Vascular Health and Risk Management 3:5, pages 721-731.
Read now
Andreas Pfützner, Matthias M Weber & Thomas Forst. (2007) Pioglitazone: update on an oral antidiabetic drug with antiatherosclerotic effects. Expert Opinion on Pharmacotherapy 8:12, pages 1985-1998.
Read now
Thomas Forst & Andreas Pfützner. (2007) Fixed-dose combination of pioglitazone and glimepiride in the treatment of Type 2 diabetes mellitus. Expert Review of Endocrinology & Metabolism 2:3, pages 303-312.
Read now
Benoit Pourcet, Jean-Charles Fruchart, Bart Staels & Corine Glineur. (2006) Selective PPAR modulators, dual and pan PPAR agonists: multimodal drugs for the treatment of Type 2 diabetes and atherosclerosis. Expert Opinion on Emerging Drugs 11:3, pages 379-401.
Read now
Andreas Pfützner, Christian A Schneider & Thomas Forst. (2006) Pioglitazone: an antidiabetic drug with cardiovascular therapeutic effects. Expert Review of Cardiovascular Therapy 4:4, pages 445-459.
Read now
Andreas Pfützner & Thomas Forst. (2006) Pioglitazone: an antidiabetic drug with the potency to reduce cardiovascular mortality. Expert Opinion on Pharmacotherapy 7:4, pages 463-476.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.